TY - JOUR
T1 - The Feasibility and Efficacy of Social Cognition and Interaction Training for Outpatients With Schizophrenia in Japan
T2 - A Multicenter Randomized Clinical Trial
AU - Kanie, Ayako
AU - Kikuchi, Akiko
AU - Haga, Daisuke
AU - Tanaka, Yuki
AU - Ishida, Akina
AU - Yorozuya, Yuko
AU - Matsuda, Yasuhiro
AU - Morimoto, Tsubasa
AU - Fukuoka, Tomoharu
AU - Takazawa, Satoru
AU - Hagiya, Kumiko
AU - Ozawa, Sachiyo
AU - Iwata, Kazuhiko
AU - Ikebuchi, Emi
AU - Nemoto, Takahiro
AU - Roberts, David L.
AU - Nakagome, Kazuyuki
N1 - Publisher Copyright:
© Copyright © 2019 Kanie, Kikuchi, Haga, Tanaka, Ishida, Yorozuya, Matsuda, Morimoto, Fukuoka, Takazawa, Hagiya, Ozawa, Iwata, Ikebuchi, Nemoto, Roberts and Nakagome.
PY - 2019/8/23
Y1 - 2019/8/23
N2 - Background: Schizophrenia is a disabling illness. Social cognition and interaction training (SCIT) seeks to improve patients’ social functioning by alleviating deficits in social cognition. SCIT has shown promise in improving social cognition in patients with schizophrenia, but has not yet been studied in Japan. Design: An assessor-masked, randomized, parallel-group clinical trial was conducted to compare the feasibility and efficacy of SCIT with treatment as usual (TAU). Setting: Participants were recruited from outpatient clinics at the National Center of Neurology and Psychiatry and four other hospitals in Japan. Participants: Seventy-two patients diagnosed with schizophrenia or schizoaffective disorder consented to participate in the trial. Procedure: Participants were randomly allocated to either a SCIT subgroup or a TAU subgroup. SCIT is a manual-based group intervention that is delivered in 20–24-h-long weekly sessions. Groups include two to three clinicians and four to eight patients. Hypotheses: We hypothesized that SCIT would be found to be feasible and that patients who were randomized to receive SCIT would exhibit improvements in social cognition. Results: Data from 32 participants in each subgroup were entered into analyses. The persistence rate in the SCIT subgroup was 88.9%, and the average attendance rate was 87.0%. Intrinsic motivation was significantly higher in the SCIT subgroup than the TAU group during the first half of the program. Mixed effects modeling of various outcome measures revealed no significant interaction between measurement timepoint and group in any measures, including social cognition, neurocognition, symptom severity, and social functioning. In the case of the social cognition measure, significant change was observed only in the SCIT subgroup; however, the interaction between timepoint and group failed to reach significance. In an exploratory subgroup analysis, a shorter duration of illness was found to be associated with significantly better improvement on the social cognition measure in the SCIT subgroup compared with the TAU subgroup. Conclusions: In terms of the primary objective, the relatively low dropout rate observed in the present study suggests that SCIT is feasible and well tolerated by patients with schizophrenia in Japan. This view is also supported by participants’ relatively high attendance and intrinsic motivation.
AB - Background: Schizophrenia is a disabling illness. Social cognition and interaction training (SCIT) seeks to improve patients’ social functioning by alleviating deficits in social cognition. SCIT has shown promise in improving social cognition in patients with schizophrenia, but has not yet been studied in Japan. Design: An assessor-masked, randomized, parallel-group clinical trial was conducted to compare the feasibility and efficacy of SCIT with treatment as usual (TAU). Setting: Participants were recruited from outpatient clinics at the National Center of Neurology and Psychiatry and four other hospitals in Japan. Participants: Seventy-two patients diagnosed with schizophrenia or schizoaffective disorder consented to participate in the trial. Procedure: Participants were randomly allocated to either a SCIT subgroup or a TAU subgroup. SCIT is a manual-based group intervention that is delivered in 20–24-h-long weekly sessions. Groups include two to three clinicians and four to eight patients. Hypotheses: We hypothesized that SCIT would be found to be feasible and that patients who were randomized to receive SCIT would exhibit improvements in social cognition. Results: Data from 32 participants in each subgroup were entered into analyses. The persistence rate in the SCIT subgroup was 88.9%, and the average attendance rate was 87.0%. Intrinsic motivation was significantly higher in the SCIT subgroup than the TAU group during the first half of the program. Mixed effects modeling of various outcome measures revealed no significant interaction between measurement timepoint and group in any measures, including social cognition, neurocognition, symptom severity, and social functioning. In the case of the social cognition measure, significant change was observed only in the SCIT subgroup; however, the interaction between timepoint and group failed to reach significance. In an exploratory subgroup analysis, a shorter duration of illness was found to be associated with significantly better improvement on the social cognition measure in the SCIT subgroup compared with the TAU subgroup. Conclusions: In terms of the primary objective, the relatively low dropout rate observed in the present study suggests that SCIT is feasible and well tolerated by patients with schizophrenia in Japan. This view is also supported by participants’ relatively high attendance and intrinsic motivation.
KW - randomized clinical trial
KW - schizophrenia
KW - social cognition
KW - social cognition and interaction training
KW - theory of mind
UR - http://www.scopus.com/inward/record.url?scp=85072189688&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072189688&partnerID=8YFLogxK
U2 - 10.3389/fpsyt.2019.00589
DO - 10.3389/fpsyt.2019.00589
M3 - Article
C2 - 31507463
AN - SCOPUS:85072189688
SN - 1664-0640
VL - 10
JO - Frontiers in Psychiatry
JF - Frontiers in Psychiatry
M1 - 589
ER -